1. Scrip
  2. >>Therapy Areas
  3. >>Anti-infective

IDRI, Zydus collaborate on leishmaniasis vaccine

 
• By Anju Ghangurde

India's Zydus Cadila and the Seattle, US-based non-profit health organization, Infectious Disease Research Institute (IDRI), are to collaborate to develop IDRI's visceral leishmaniasis (VL) vaccine candidate.

India's Zydus Cadila and the Seattle, US-based non-profit health organization, Infectious Disease Research Institute (IDRI), are to collaborate to develop IDRI's visceral leishmaniasis (VL) vaccine candidate.

The partners expect to conduct clinical development activities in India aimed at developing, registering and marketing the product. Affordability and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Anti-infective

Moderna’s Spikevax Wins Pediatric Approval, But With Narrower Label

 
• By Alaric DeArment

The approval for young children, consistent with the FDA’s new COVID-19 vaccine policy, restricts Spikevax to those with conditions putting them at higher risk.

Four Chinese Firms Snag Global First-In-Class Approvals In China

 
• By Dexter Jie Yan

Four Chinese companies have won approvals in China, the first anywhere, for novel drugs for diffuse large B-cell lymphoma, certain types of non-small cell lung cancer and influenza A.

In Brief: BioVersys And Shionogi Align In Non-Tuberculous Mycobacteria R&D

 
• By Joseph Haas

Deal Snapshot: Having recently raised an $89m IPO, BioVersys is partnering on and optioning rights to a preclinical NTM development program with Shionogi.

Moderna Posts Phase III Efficacy Data For Flu Vaccine

 
• By Joseph Haas

With positive relative efficacy data for its mRNA seasonal flu shot, Moderna hopes to file mRNA-1010 for US approval and refile a COVID-19/flu combo shot that it withdrew in May.

More from Therapy Areas